Brookstone Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.9M | Buy |
91,033
+2,099
| +2% | +$452K | 0.23% | 119 |
|
|
2026
Q1 | $19.3M | Sell |
88,934
-2,480
| -3% | -$550K | 0.22% | 115 |
|
|
2025
Q4 | $20.9M | Sell |
91,414
-6,299
| -6% | -$1.43M | 0.24% | 106 |
|
|
2025
Q3 | $22.6M | Buy |
97,713
+20,100
| +26% | +$4.09M | 0.27% | 93 |
|
|
2025
Q2 | $14.4M | Sell |
77,613
-2,453
| -3% | -$456K | 0.19% | 128 |
|
|
2025
Q1 | $16.8M | Sell |
80,066
-4,686
| -6% | -$911K | 0.24% | 103 |
|
|
2024
Q4 | $15.1M | Sell |
84,752
-3,142
| -4% | -$578K | 0.22% | 109 |
|
|
2024
Q3 | $17.4M | Sell |
87,894
-294
| -0.3% | -$54.9K | 0.26% | 94 |
|
|
2024
Q2 | $15.5M | Buy |
88,188
+5,175
| +6% | +$857K | 0.26% | 93 |
|
|
2024
Q1 | $15.1M | Buy |
83,013
+3,006
| +4% | +$518K | 0.27% | 88 |
|
|
2023
Q4 | $12.4M | Buy |
80,007
+3,536
| +5% | +$516K | 0.24% | 112 |
|
|
2023
Q3 | $11.1M | Sell |
76,471
-20,164
| -21% | -$2.96M | 0.24% | 119 |
|
|
2023
Q2 | $13.1M | Buy |
96,635
+8,119
| +9% | +$1.19M | 0.26% | 110 |
|
|
2023
Q1 | $14.3M | Buy |
88,516
+6,908
| +8% | +$1.06M | 0.28% | 102 |
|
|
2022
Q4 | $13.6M | Sell |
81,608
-10,894
| -12% | -$1.67M | 0.28% | 101 |
|
|
2022
Q3 | $12.9M | Sell |
92,502
-15,456
| -14% | -$2.22M | 0.3% | 84 |
|
|
2022
Q2 | $16.5M | Buy |
107,958
+12,368
| +13% | +$1.89M | 0.37% | 74 |
|
|
2022
Q1 | $16.2M | Sell |
95,590
-31,151
| -25% | -$4.53M | 0.32% | 76 |
|
|
2021
Q4 | $17.1M | Sell |
126,741
-1,466
| -1% | -$173K | 0.29% | 79 |
|
|
2021
Q3 | $13.9M | Buy |
128,207
+22,634
| +21% | +$2.59M | 0.25% | 85 |
|
|
2021
Q2 | $12.4M | Buy |
105,573
+40,090
| +61% | +$4.52M | 0.22% | 93 |
|
|
2021
Q1 | $7.09M | Sell |
65,483
-4,354
| -6% | -$466K | 0.27% | 82 |
|
|
2020
Q4 | $7.48M | Buy |
69,837
+4,584
| +7% | +$441K | 0.3% | 64 |
|
|
2020
Q3 | $5.72M | Buy |
65,253
+19,130
| +41% | +$1.8M | 0.26% | 60 |
|
|
2020
Q2 | $4.53M | Sell |
46,123
-12,763
| -22% | -$1.12M | 0.28% | 55 |
|
|
2020
Q1 | $4.49M | Sell |
58,886
-10,778
| -15% | -$918K | 0.26% | 54 |
|
|
2019
Q4 | $6.17M | Buy |
69,664
+9,840
| +16% | +$817K | 0.31% | 49 |
|
|
2019
Q3 | $4.53M | Buy |
59,824
+14,768
| +33% | +$1.01M | 0.25% | 62 |
|
|
2019
Q2 | $3.28M | Buy |
45,056
+6,430
| +17% | +$505K | 0.19% | 78 |
|
|
2019
Q1 | $3.11M | Buy |
38,626
+14,811
| +62% | +$1.21M | 0.2% | 74 |
|
|
2018
Q4 | $2.2M | Buy |
23,815
+2,123
| +10% | +$187K | 0.17% | 91 |
|
|
2018
Q3 | $2.05M | Buy |
21,692
+3,637
| +20% | +$345K | 0.16% | 135 |
|
|
2018
Q2 | $1.67M | Buy |
18,055
+5,825
| +48% | +$569K | 0.15% | 127 |
|
|
2018
Q1 | $1.16M | Buy |
12,230
+1,594
| +15% | +$175K | 0.11% | 135 |
|
|
2017
Q4 | $1.03M | Sell |
10,636
-59,680
| -85% | -$5.62M | 0.09% | 139 |
|
|
2017
Q3 | $6.25M | Sell |
70,316
-20,010
| -22% | -$1.52M | 0.57% | 52 |
|
|
2017
Q2 | $6.55M | Sell |
90,326
-3,210
| -3% | -$216K | 0.62% | 52 |
|
|
2017
Q1 | $6.09M | Buy |
93,536
+7,946
| +9% | +$500K | 0.62% | 54 |
|
|
2016
Q4 | $5.36M | Buy |
85,590
+14,802
| +21% | +$904K | 0.59% | 59 |
|
|
2016
Q3 | $4.46M | Buy |
70,788
+7,174
| +11% | +$464K | 0.49% | 59 |
|
|
2016
Q2 | $3.94M | Buy |
63,614
+7,885
| +14% | +$480K | 0.51% | 46 |
|
|
2016
Q1 | $3.18M | Buy |
55,729
+50,777
| +1,025% | +$2.83M | 0.48% | 51 |
|
|
2015
Q4 | $293K | Sell |
4,952
-699
| -12% | -$40.3K | 0.06% | 123 |
|
|
2015
Q3 | $307K | Sell |
5,651
-331
| -6% | -$21.5K | 0.06% | 118 |
|
|
2015
Q2 | $402K | Buy |
5,982
+1,441
| +32% | +$94.1K | 0.05% | 152 |
|
|
2015
Q1 | $266K | Sell |
4,541
-262
| -5% | -$15.8K | 0.04% | 153 |
|
|
2014
Q4 | $314K | Sell |
4,803
-8,531
| -64% | -$538K | 0.05% | 129 |
|
|
2014
Q3 | $770K | Buy |
13,334
+8,676
| +186% | +$482K | 0.14% | 54 |
|
|
2014
Q2 | $263K | Buy |
4,658
+208
| +5% | +$10.9K | 0.05% | 96 |
|
|
2014
Q1 | $229K | Sell |
4,450
-128
| -3% | -$6.47K | 0.06% | 104 |
|
|
2013
Q4 | $242K | Buy |
+4,578
| New | +$225K | 0.07% | 101 |
|
Other funds holding ABBV
Brookstone Capital Management's ABBV Position: Q2 2026 in Review
Brookstone Capital Management increased its AbbVie (ABBV) stake by 2.4% in Q2 2026, buying an estimated $452K and bringing the position to 91,033 shares worth $22.9M. The position accounts for 0.23% of the portfolio, ranked #119.
Brookstone Capital Management first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Brookstone Capital Management held 91,033 shares of AbbVie worth $22.9M as of Q2 2026.
- Brookstone Capital Management bought 2,099 AbbVie shares in Q2 2026, an estimated $452K.
- AbbVie made up 0.23% of Brookstone Capital Management's portfolio in Q2 2026, its #119 holding.
- Brookstone Capital Management first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
- 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.